An easy and innovative test to detect
colorectal cancer in blood.
Amadix develops and commercializes breakthrough discoveries in cancer diagnosis with a clear commercial rationale, addressing unmet medical needs in oncology.
Top level management team with extensive experience in cancer diagnostics.
Know more about ColoFast
Amadix is actively looking for further innovative projects in cancer diagnosis with a clear commercial rationale, coming from universities, hospitals and research institutions, to broaden its current pipeline through in-licensing of cutting edge technology.